BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22735029)

  • 1. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
    Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
    Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
    Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
    Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
    Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
    Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations associated with progression and recurrence in meningiomas.
    Pérez-Magán E; Campos-Martín Y; Mur P; Fiaño C; Ribalta T; García JF; Rey JA; Rodríguez de Lope A; Mollejo M; Meléndez B
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):882-93. PubMed ID: 22964784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of extracellular matrix-related genes in rare variants of meningioma.
    Kwon MJ; Sung CO; Kang SY; Do IG; Suh YL
    Hum Pathol; 2013 Feb; 44(2):260-8. PubMed ID: 22995327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylation and expression analysis of p16(INK4a) and RB genes in meningiomas].
    Chen MN; Mao Q; Liu YH; Mao BY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):277-9. PubMed ID: 15192837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation markers of malignant potential in meningiomas.
    Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
    J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
    Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression.
    Sayagués JM; Tabernero MD; Maíllo A; Trelles O; Espinosa AB; Sarasquete ME; Merino M; Rasillo A; Vera JF; Santos-Briz A; de Alava E; Garcia-Macias MC; Orfao A
    J Neuropathol Exp Neurol; 2006 May; 65(5):445-54. PubMed ID: 16772868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient gender is associated with distinct patterns of chromosomal abnormalities and sex chromosome linked gene-expression profiles in meningiomas.
    Tabernero MD; Espinosa AB; Maillo A; Rebelo O; Vera JF; Sayagues JM; Merino M; Diaz P; Sousa P; Orfao A
    Oncologist; 2007 Oct; 12(10):1225-36. PubMed ID: 17962616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
    Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
    Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
    Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in the malignant transformation of meningiomas.
    Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K
    PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
    Monleón D; Morales JM; Gonzalez-Darder J; Talamantes F; Cortés O; Gil-Benso R; López-Ginés C; Cerdá-Nicolás M; Celda B
    J Proteome Res; 2008 Jul; 7(7):2882-8. PubMed ID: 18507434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.